Semaglutide

FDA Approved

Also known as: Ozempic, Wegovy, Rybelsus

GLP-1 / Weight LossSubcutaneousOral

A GLP-1 receptor agonist used for type 2 diabetes and weight management. One of the most studied peptides for metabolic health.

Molecular Weight4113.6 Da

Half-Life (t½)~7 days

SequenceModified GLP-1 analog (31 amino acids)

Mechanism of Action

Mimics GLP-1 hormone, stimulating insulin secretion, suppressing glucagon, slowing gastric emptying, and promoting satiety via hypothalamic signaling.

Dosing Protocol

Titration schedule: Start 0.25mg/week for 4 weeks, increase to 0.5mg, then 1mg, up to 2.4mg/week for weight management.

Open peptide calculator

Reconstitution

Typically supplied pre-mixed. Research-grade: 5mg vial + 2mL BAC water.

Storage

Refrigerate 2-8°C. Do not freeze. Protect from light.

Side Effects

●Nausea
●Vomiting
●Diarrhea
●Constipation
●Abdominal pain

Key Research Findings

●STEP trials: 15-17% body weight reduction
●SELECT trial: 20% cardiovascular risk reduction
●Significant HbA1c reduction in diabetes management

Latest Verified Lab Report

No lab reports available for Semaglutide yet.

Community-funded testing results will appear here.

Vendor Trust Leaderboard

For Semaglutide

Trust leaderboard coming soon.

Vendor rankings based on verified lab test results.

Active Deals

Gen Peptide

10% OFF

Shop Vendor